Background::Low-grade gliomas (LGG) are WHO grade II tumors presenting as the most common primary malignant brain tumors in adults. Currently, LGG treatment involves either or a combination of surgery, radiation therapy, and chemotherapy. Despite the knowledge of constitutive genetic risk factors contributing to gliomas, the role of single genes as diagnostic and prognostic biomarkers is limited. The aim of the current study is to discover the predictive and prognostic genetic markers for LGG.Methods::Transcriptome data and clinical data were obtained from The Cancer Genome Atlas (TCGA) database. We first performed the tumor microenvironment (TME) survival analysis using the Kaplan-Meier method. An analysis was undertaken to screen for differentially expressed genes. The function of these genes was studied by Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Following which a protein-protein interaction network (PPI) was constructed and visualized. Univariate and multivariate COX analyses were performed to obtain the probable prognostic genes. The key genes were selected by an intersection of core and prognostic genes. A clinical correlation analysis of single-gene expression was undertaken. GSEA enrichment analysis was performed to identify the function of key genes. Finally, a single gene-related correlation analysis was performed to identify the core immune cells involved in the development of LGG.Results::A total of 529 transcriptome data and 515 clinical samples were obtained from the TCGA. Immune cells and stromal cells were found to be significantly increased in the LGG microenvironment. The top five core genes intersected with the top 38 prognostically relevant genes and two key genes were identified. Our analysis revealed that a high expression of HLA-DRA was associated with a poor prognosis of LGG. Correlation analysis of immune cells showed that HLA-DRA expression level was related to immune infiltration, positively related to macrophage M1 phenotype, and negatively related to activation of NK cells.Conclusions::HLA-DRA may be an independent prognostic indicator and an important biomarker for diagnosing and predicting survival in LGG patients. It may also be associated with the immune infiltration phenotype in LGG.

Low-grade gliomas;HLA-DRA;Glioma;Immune;TEM;Biomarker

Chen Desheng;Yao Jiawei;Hu Bowen;Kuang Liangwen;Xu Binshun;Liu Haiyu;Dou Chao;Wang Guangzhi;Guo Mian

Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, 246 Xuefu Road, Nangang, Harbin 150086, Heilongjiang, China

中华神经外科杂志（英文）

[1]Chen Desheng;Yao Jiawei;Hu Bowen;Kuang Liangwen;Xu Binshun;Liu Haiyu;Dou Chao;Wang Guangzhi;Guo Mian-.New biomarker: the gene HLA-DRA associated with low-grade glioma prognosis)[J].中华神经外科杂志（英文）,2022(03):169-177

prognostically

New,HLA,DRA,associated,grade,prognosis,Background,Low,gliomas,LGG,are,WHO,II,tumors,presenting,most,common,primary,malignant,brain,adults,Currently,treatment,involves,either,combination,surgery,radiation,chemotherapy,Despite,knowledge,constitutive,genetic,risk,factors,contributing,role,single,genes,diagnostic,biomarkers,limited,aim,current,study,discover,predictive,Methods,Transcriptome,clinical,were,obtained,from,Cancer,Atlas,TCGA,database,We,first,performed,microenvironment,TME,survival,analysis,using,Kaplan,Meier,method,An,was,undertaken,screen,differentially,expressed,function,these,studied,by,Ontology,enrichment,Kyoto,Encyclopedia,Genes,Genomes,pathway,Following,which,protein,interaction,network,PPI,constructed,visualized,Univariate,multivariate,COX,analyses,probable,key,selected,intersection,core,correlation,expression,GSEA,identify,Finally,related,immune,cells,involved,development,Results,total,transcriptome,samples,Immune,stromal,found,be,significantly,increased,top,five,intersected,relevant,identified,Our,revealed,that,high,poor,Correlation,showed,level,infiltration,positively,macrophage,M1,phenotype,negatively,activation,NK,Conclusions,may,independent,indicator,important,diagnosing,predicting,patients,It,also,Glioma,TEM,Biomarker

0.496511